Introduction
The little word 'polyp' has probably caused as much confusion as any other commonly used in modem medical nomenclature. Indeed, it has been used with such diverse meaning as to create barriers of misunderstanding which in turn have adversely affected the care of patients. Precision in the use of words, without being pedantic, is clearly desirable but attempts to reach general agreement about how the meaning of a word (and its synonyms) is to be conveyed can be fraught with controversy. That august body, the World Health Organization, among others, has spent large sums of money arranging for experts from all over the world to gather together for discussions on the nomenclature and classification of disease which, in the experience of this writer, can be somewhat acrimonious and consensus of opinion may be difficult or impossible to achieve. The end result is more likely to be a reflection of majority opinion rather than universal agreement. The 'polyp story' is a good example of how one word used with different meaning can create such confusion and misunderstanding that meaningful communication between its users may breakdown.
What is a polyp? Sir John Bland-Sutton, one of the great Surgeon-Pathologists of the early 20th Century, was among the first to emphasize that the word polyp had no place in tissue (histological) diagnosis. He pointed out that 'the ancient name polypus applied to benign tumours attached to mucous membrane by means of a stalk has merely a clinical value' (Bland-Sutton, 1922) . But he also made a clear distinction between a stalked polyp and a sessile papilloma, a notion which is no longer acceptable in modem nomenclature and classification of colorectal tumours, although there are still surgeons, and even pathologists, who find difficulty in understanding why the name papilloma should be abandoned for the newer expression 'villous adenoma'.
It was really Westhues in his exquisitely illustrated monograph who laid the foundation for the modem nomenclature and classification of benign tumours of the colorectum (Westhues, 1934 been well documented but is important to remember that these are not clear cut categories, but only different manifestations of a spectrum of abnormal tissue architecture (Konishi and Morson, 1982) .
The older synonyms such as villo-glandular adenoma and villous papilloma are being abandoned although adenomatous polyp is still commonly used. It would be better to reach uniformity in practice by using the recommended WHO Classification. The cellular changes in adenomas are the same whatever the histological type and can be graded subjectively into mild, moderate and severe dysplasia, the latter being closest to invasive carcinoma. Severe dysplasia is used synonymously by some with the expression carcinoma-in-situ but the author has always held the view that the latter term is emotive and can label a patient as having 'cancer' when such a serious diagnosis is unjustified. For many patients the words cancer or carcinoma however qualified can create fear and loss of hope and certainly a word that should be avoided when dealing with a lesion which is known to be easily curable by local removal. Although there are differences the cellular features of dysplasia in adenomas have much in common with the dysplasia seen as a consequence of long-s anding ulcerative colitis, in the mucous membrane of the stomach and in the squamous mucous memi rane of the oesophagus. Moreover, the word dyspl sia has general applicability in the description of histopathological precursor lesions for cancer in a variety of epithelial surfaces both within and without the gastrointestinal tract. Dysplasia of the uterin cervix is the best known example. Conceptually it now appears advantageous to think in terms of the dysplasia-carcinoma sequence in the gastroir.testinal tract rather than the polyp-cancer or adenomacarcinoma sequence.
The importance of the adenoma lies in its i ole as a marker of increased colorectal cancer risk. It is a common lesion in those western countries, 3articu-larly the United States, where the incidince of colorectal cancer is high. For some years ncw there has been general acceptance of the concep; of the adenoma-carcinoma sequence, although it must be emphasized that only a minority of adenomas are destined to become cancerous and the time sequence of adenoma to carcinoma may take many years. Probably this is always at least five years and in some patients may be as long as a quarter of a century (Muto, Bussey and Morson, 1975 The concept of the adenoma-carcinoma sequence has been used by some to justify short interval (even as little as three months) colonoscopic surveillance despite the evidence that generally the evolution of the sequence is slow. Thus, the discovery of a 'polyp' continues to be used by some as an indication for frequent endoscopic examinations. The fact is that at the present time we do not know how frequently examination should take place, and until more selective and sensitive markers of cancer risk are available it is best to adopt a cautious approach to the management of adenoma patients. This type of polyp is so common that it is not practicable or cost effective to subject all such patients to follow-up and repeated investigation. Prospective studies are required which hopefully will identify small, manageable groups of patients at especially high risk and it is these who would be most likely to benefit from any long-term cancer prevention programmes.
The notion that the removal of adenomas can be equated with prevention of bowel cancer is theoretically correct, but there is no justification at the present time for regular and indefinite endoscopic follow-up of all adenoma patients over many years (with the attendant risk of inducing cancerophobia) other than as a research project in special centres. Moreover, indiscriminate follow-up of this kind is expensive and wasteful of medical expertise. It is unfortunate that the words 'polyp' and 'adenoma' have acquired an emotive meaning for both doctors and patients which is out of all proportion to the reality of the situation. These comments are not designed to inhibit attempts at prevention of bowel cancer in individual patients if there is sufficient justification, but there is real danger that overreaction will lead not only to unnecessary investigation of patients but will harm attempts to design meaningful cancer prevention programmes.
The introduction of fibreoptic colonoscopy has been revolutionary in its effects. Not only is it a highly successful weapon for the removal of polyps from all parts of the large bowel but it has provided pathologists with an abundance of material for study. There is now a real chance that prospective studies will give a clearer picture of the magnitude of cancer risk, for different groups of patients with different histological types and numbers of adenomas. However, research using the techniques of cytogenetics, cell culture and immunocytochemistry among others may well produce in the future those highly selective markers of cancer risk which are required if organized cancer prevention in clinical practice is to become a reality. Meanwhile, the recognition of a polyp or a state of polyposis by endoscopic and radiological techniques must be followed by accurate histological typing and the use of agreed nomenclature which is meaningful to those who have care of patients.
